Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK Trial.
Guedeney P, Barthélémy O, Zeitouni M, Hauguel-Moreau M, Hage G, Kerneis M, Lattuca B, Overtchouk P, Rouanet S, Fuernau G, de Waha-Thiele S, Zeymer U, Sandri M, Akin I, Desch S, Thiele H, Montalescot G. Guedeney P, et al. Among authors: rouanet s. JACC Cardiovasc Interv. 2020 May 25;13(10):1198-1206. doi: 10.1016/j.jcin.2020.04.003. JACC Cardiovasc Interv. 2020. PMID: 32438990 Free article. Clinical Trial.
Aldosterone and long-term outcome after myocardial infarction: A substudy of the french nationwide Observatoire sur la Prise en charge hospitalière, l'Evolution à un an et les caRactéristiques de patients présentant un infArctus du myocarde avec ou sans onde Q (OPERA) study.
Beygui F, Montalescot G, Vicaut E, Rouanet S, Van Belle E, Baulac C, Degrandsart A, Dallongeville J; OPERA Investigators. Beygui F, et al. Among authors: rouanet s. Am Heart J. 2009 Apr;157(4):680-7. doi: 10.1016/j.ahj.2008.12.013. Epub 2009 Mar 17. Am Heart J. 2009. PMID: 19332195
Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI Registry.
Overtchouk P, Guedeney P, Rouanet S, Verhoye JP, Lefevre T, Van Belle E, Eltchaninoff H, Gilard M, Leprince P, Iung B, Barthelemy O, Le Breton H, Souteyrand G, Vicaut E, Montalescot G, Collet JP. Overtchouk P, et al. Among authors: rouanet s. J Am Coll Cardiol. 2019 Jan 8;73(1):13-21. doi: 10.1016/j.jacc.2018.08.1045. Epub 2018 Aug 25. J Am Coll Cardiol. 2019. PMID: 30153483 Free article.
Investigator Versus Core Laboratory Evaluation of Coronary Flow and Related Mortality in the CULPRIT-SHOCK Trial.
Zeitouni M, Barthélémy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Hage G, Overtchouk P, Brugier D, Vignolles N, Kerneis M, Silvain J, Collet JP, Vicaut E, Desch S, Zeymer U, Thiele H, Montalescot G. Zeitouni M, et al. Among authors: rouanet s. Circ Cardiovasc Interv. 2019 Oct;12(10):e008296. doi: 10.1161/CIRCINTERVENTIONS.119.008296. Epub 2019 Oct 14. Circ Cardiovasc Interv. 2019. PMID: 31607157 Clinical Trial. No abstract available.
Incidence of, risk factors for and impact of readmission for heart failure after successful transcatheter aortic valve implantation.
Guedeney P, Huchet F, Manigold T, Rouanet S, Balagny P, Leprince P, Lebreton G, Letocart V, Barthelemy O, Vicaut E, Montalescot G, Guerin P, Collet JP; ACTION Study Group. Guedeney P, et al. Among authors: rouanet s. Arch Cardiovasc Dis. 2019 Dec;112(12):765-772. doi: 10.1016/j.acvd.2019.09.008. Epub 2019 Nov 20. Arch Cardiovasc Dis. 2019. PMID: 31759916 Free article.
Effect of oral anticoagulation on clinical outcomes and haemodynamic variables after successful transcatheter aortic valve implantation.
Guedeney P, Huchet F, Manigold T, Overtchouk P, Rouanet S, Balagny P, Leprince P, Lebreton G, Letocart V, Barthelemy O, Vicaut E, Montalescot G, Guerin P, Collet JP; ACTION Study Group. Guedeney P, et al. Among authors: rouanet s. Arch Cardiovasc Dis. 2020 May;113(5):341-349. doi: 10.1016/j.acvd.2019.12.008. Epub 2020 Feb 27. Arch Cardiovasc Dis. 2020. PMID: 32115397 Free article.
Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial.
Guedeney P, Thiele H, Kerneis M, Barthélémy O, Baumann S, Sandri M, de Waha-Thiele S, Fuernau G, Rouanet S, Piek JJ, Landmesser U, Hauguel-Moreau M, Zeitouni M, Silvain J, Lattuca B, Windecker S, Collet JP, Desch S, Zeymer U, Montalescot G, Akin I; CULPRIT-SHOCK Investigators. Guedeney P, et al. Among authors: rouanet s. Am Heart J. 2020 Jul;225:60-68. doi: 10.1016/j.ahj.2020.04.014. Epub 2020 Apr 30. Am Heart J. 2020. PMID: 32497906 Clinical Trial.
Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy.
Overtchouk P, Barthélémy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Zeitouni M, Silvain J, Collet JP, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G; Collaborators. Overtchouk P, et al. Among authors: rouanet s. EuroIntervention. 2021 Feb 5;16(15):e1237-e1244. doi: 10.4244/EIJ-D-20-00139. EuroIntervention. 2021. PMID: 32624460 Free PMC article. Clinical Trial.
70 results